In vivo imaging of graftversus-host disease and graftversus-leukemia - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 77

[38] Youngnak-Piboonratanakit P, Tsushima F, Otsuki N, et al. The expression of B7-H1 on
keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role.
Immunol Lett 2004;94:215-22.
[39] Muhlbauer M, Fleck M, Schutz C, et al. PD-L1 is induced in hepatocytes by viral infec-
tion and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol
2006;45:520-8.
[40] Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and im-
munity. Annu Rev Immunol 2008;26:677-704.
[41] Lan F, Zeng D, Higuchi M, Higgins JP, Strober S. Host conditioning with total lymphoid
irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of
CD1-reactive natural killer T cells. Biol Blood Marrow Transplant 2003;9:355-63.
[42] Leveson-Gower DB, Olson JA, Sega EI, et al. Low doses of natural killer T cells provide
protection from acute graft-versus-host disease via an IL-4-dependent mechanism.
Blood 2011;117:3220-9.
[43] Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance main-
tained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of
a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol
1995;155:1151-64.
[44] Edinger M, Hoffmann P, Ermann J, et al. CD4 + CD25 + regulatory T cells preserve graft-
versus-tumor activity while inhibiting graft-versus-host disease after bone marrow
transplantation. Nat Med 2003;9:1144-50.
[45] Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4( + )CD25( + )
regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone
marrow transplantation. J Exp Med 2002;196:389-99.
[46] Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4( + )CD25( + ) immunoregu-
latory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002;196:401-6.
[47] Trenado A, Charlotte F, Fisson S, et al. Recipient-type specific CD4+CD25+ regulatory
T cells favor immune reconstitution and control graft-versus-host disease while main-
taining graft-versus-leukemia. J Clin Invest 2003;112:1688-96.
[48] Nguyen VH, Zeiser R, Dasilva DL, et al. In vivo dynamics of regulatory T-cell trafficking
and survival predict effective strategies to control graft-versus-host disease following
allogeneic transplantation. Blood 2007;109:2649-56.
[49] Zeiser R, Nguyen VH, Hou JZ, et al. Early CD30 signaling is critical for adoptively trans-
ferred CD4 + CD25 + regulatory T cells in prevention of acute graft-versus-host disease.
Blood 2007;109:2225-33.
[50] Tadokoro CE, Shakhar G, Shen S, et al. Regulatory T cells inhibit stable contacts be-
tween CD4+ T cells and dendritic cells in vivo . J Exp Med 2006;203:505-11.
[51] Tang Q, Adams JY, Tooley AJ, et al. Visualizing regulatory T cell control of autoimmune
responses in nonobese diabetic mice. Nat Immunol 2006;7:83-92.
[52] Chen ML, Pittet MJ, Gorelik L, et al. Regulatory T cells suppress tumor-specific CD8 T
cell cytotoxicity through TGF-beta signals in vivo . Proc Natl Acad Sci USA 2005;102:419-
24.
[53] Fahlen L, Read S, Gorelik L, et al. T cells that cannot respond to TGF-beta escape con-
trol by CD4( + )CD25( + ) regulatory T cells. J Exp Med 2005;201:737-46.
[54] Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA. CD4 + CD25 + T regulatory cells
control anti-islet CD8 + T cells through TGF-beta-TGF-beta receptor interactions in type
1 diabetes. Proc Natl Acad Sci USA 2003;100:10878-83.
[55] Di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHD and promote immune recon-
stitution in HLA-haploidentical transplantation. Blood 2011;117:3921-8.
[56] Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4( + )
CD25( + ) immune regulatory cells inhibits graft-versus-host disease lethality. Blood
2002;99:3493-9.
[57] Hippen KL, Merkel SC, Schirm DK, et al. Massive ex vivo expansion of human natural
regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl
Med 2011;3; 83ra41.
[58] Hoffmann P, Eder R, Boeld TJ, et al. Only the CD45RA + subpopulation of
CD4 + CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro
expansion. Blood 2006;108:4260-7.
[59] Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in
adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Blood 2011;117:1061-70.
[60] Zeiser R, Nguyen VH, Beilhack A, et al. Inhibition of CD4 + CD25 + regulatory T-cell func-
tion by calcineurin-dependent interleukin-2 production. Blood 2006;108:390-9.
[61] Zeiser R, Leveson-Gower DB, Zambricki EA, et al. Differential impact of mammalian
target of rapamycin inhibition on CD4 + CD25 + Foxp3 + regulatory T cells compared with
conventional CD4 + T cells. Blood 2008;111:453-62.

78